All Insights
Showing 205 - 216 of 400
Life Sciences and Healthcare
Judicial review highlights pharmaceutical industry concerns over VPAS in UK
Negotiations for new voluntary scheme being challenged by industry body as old scheme is criticised for amount levied on suppliers
Regulatory Outlook
Products | UK Regulatory Outlook June 2023
General Product Safety Regulation enters into force | Council of the EU adopt position on new Product Liability Directive |
Life Sciences and Healthcare
UK gives guidance for manufacturers on reporting adverse SaMD incidents
Businesses should consult the guidelines and familiarise themselves with the issues to report and systems to implement
Life Sciences and Healthcare
Use of trade mark for food supplements does not amount to genuine use for pharma products
Food supplements are not considered as a sub-set of pharmaceutical products in class 5 for proving genuine trade mark use
Life Sciences and Healthcare
Pharma impacted by new EU packaging and packaging waste proposals
The European Commission concludes its feedback period from stakeholders on its draft regulation
Regulatory and compliance
'Vet-ting' medicinal claims in Great Britain: top tips on advertising pet products with health benefits
Complying with regulatory requirements and ensuring that advertising and marketing copy is accurate increases consumer confidence in brands
Life Sciences and Healthcare
European Commission publishes proposal for new EU pharmaceutical legislation
The EU Commission is planning to revise the pharmaceutical legislation in Europe to make medicinal products more available, accessible and
Intellectual property
UK sets out the new Science and Technology Framework
Government growth ambitions for critical technologies including AI and future telecoms require regulatory clarity
Tax
Spring Budget 2023 | What tax measures were announced?
A budget for growth but no cuts in tax rates
Life Sciences and Healthcare
Spring Budget 2023 | UK chancellor announces new regulatory model for medicines and medical technologies
Move raises the question of whether regulatory framework for medicines and medical devices will diverge from the EU model in
Regulatory and compliance
Consultation opens on proposed revisions to the Veterinary Medicines Regulations in Great Britain
Businesses involved in the manufacture, distribution and dispensation of veterinary medicinal products should take the opportunity to respond before the
Regulatory Outlook
Products | UK Regulatory Outlook February 2023
Medical Technology Strategy | UK to introduce regulatory framework for point of care manufacturing | Commission launches call for evidence
